Clinical Trials Browser

Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Mesothelioma, Sarcoma, Sarcoma, Synovial, Lymphoma, Large B-Cell, Diffuse, Rhabdoid Tumor, Hematologic Neoplasms

NCT02895529 2019-05-06

A Study Comparing the Efficacy of Intravenous Followed by Oral Itraconazole With Intravenous Caspofungin For Empiric Antifungal Therapy in Neutropenic Participants With Hematological Malignancy

Phase 4 Terminated

61 enrolled

Other hematologic neoplasm

Hematologic Neoplasms

NCT00045942 2017-08-11

PKC412 in Participants With Acute Myeloid Leukemia or With Myelodysplastic Syndrome (CPKC412A2104 Core); and PKC412 in Participants With Acute Myeloid Leukemia or With Myelodysplastic Syndrome With Either Wild Type or Mutated FMS-like Tyrosine Kinase 3 (FLT3) (CPKC412A2104E1 and CPKC412A2104E2)

Phase 1/2 Completed

144 enrolled 48 charts

MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT01021683 2013-08-12

The Relationship of Defeverscence and Itraconazole Plasma Level Study in Immunocompromised Participants

Completed

203 enrolled 14 charts

Other hematologic neoplasm

Fever, Neutropenia, Hematologic Neoplasms

NCT01706562 2013-02-20

A Study of Empirical Antifungal Therapy With Itraconazole

Completed

138 enrolled

Classical hematologyOther hematologic neoplasm

Mycoses, Neutropenia, Hematologic Neoplasms, Febrile Neutropenia

Clinical Trials

First in Human Study of Ziftomenib in Relapsed or Refractory Acute Myeloid Leukemia

Clinical Study Aiming to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of a Single Administration of ZE50-0134 at 5 Dose Levels in Healthy Volunteers

AMG 176 First in Human Trial in Participants With Relapsed or Refractory Multiple Myeloma and Participants With Relapsed or Refractory Acute Myeloid Leukemia

Effects of Itraconazole and Rifampin on the Blood Tazemetostat Levels

A Study Comparing the Efficacy of Intravenous Followed by Oral Itraconazole With Intravenous Caspofungin For Empiric Antifungal Therapy in Neutropenic Participants With Hematological Malignancy

PKC412 in Participants With Acute Myeloid Leukemia or With Myelodysplastic Syndrome (CPKC412A2104 Core); and PKC412 in Participants With Acute Myeloid Leukemia or With Myelodysplastic Syndrome With Either Wild Type or Mutated FMS-like Tyrosine Kinase 3 (FLT3) (CPKC412A2104E1 and CPKC412A2104E2)

The Relationship of Defeverscence and Itraconazole Plasma Level Study in Immunocompromised Participants

A Study of Empirical Antifungal Therapy With Itraconazole